Betaine anhydrous 1 GM/Scoop Powder for Oral Solution
RxNorm 562847
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 562847 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: betaine anhydrous 1 GM/Scoop Powder for Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Betaine 1000 mg Powder for Oral Solution
(Atom ID: 12334297)
PSNPrescribable
Prescribable Name (PSN):
Betaine anhydrous 1 GM/Scoop Powder for Oral Solution
(Atom ID: 8249320)
SYPrescribable
Synonym (SY):
Betaine anhydrous 1 GM/Scoop Powder for Oral Solution
(Atom ID: 8249321)
Patient Education
Betaine
Betaine is used to treat homocystinuria (an inherited condition in which the body cannot break down a certain protein, causing build-up of homocysteine in the blood). Increased amounts of homocysteine in the body can cause symptoms such as extreme tiredness, seizures, dislocation of the lens of the eye, abnormal bone structure, osteoporosis (weak bones), blood clots, or decreased weight or rate of weight gain and slowed development in children. Betaine is in a class of medications called nutrients. It works by decreasing the amount of homocysteine in the blood.
[Learn More]
* Please review the disclaimer below.